# OnCo record nct07286331 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07286331/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07286331", "NCT07286331" ;
  schema:name "A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)"@en ;
  schema:alternateName "BEHOLD-Endometrial01"@en ;
  schema:description "A phase 3 trial of Doxorubicin in endometrial cancer, run by GlaxoSmithKline, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07286331/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07286331> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2026-06-04" ;
  onco:cancers <https://onco.cc/cancers/endometrial/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/doxorubicin/> ;
  onco:companies <https://onco.cc/companies/gsk/> .